Zhejiang Arthur Pharmaceutical Co.
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- Undisclosed
Investors
- 12
About Zhejiang Arthur Pharmaceutical Co.
, Ltd is a drugs' developer that provides generic and innovative drugs. It was recognized as a National High-Tech Enterprise, and has over 2000 square meters of R&D centers located in the USA and Jiaxing. The company has about 100 employees and more than 50% of them have master's degree. The core research team mostly graduated from East China University of Science and Technology, China Pharmaceutical University and Shenyang Pharmaceutical University. Arthur Pharmaceutical mainly provides generic and innovative drugs. Its products include oral solid, sterile and semi-solid. Sterile includes lyophilization, drops, liquid self-emulsifying formulations, nanoparticle suspension and liposomes. The products can be used in the treatment of cardiovascular diseases, gastrointestinal disorders, diabetes, central nervous system disorders, as well as for anti-infective and anti-tumor applications. Arthur has more than 60 sets of precision testing instruments and more than 50 sets of preparation synthesis small test and pilot equipment. The company also offers CRO, CMO and CDMO services. The company generates revenue by offering CRO, CMO and CDMO services and pharmaceuticals such as tablets, capsules, injectables, semi-solid. The company will expand its strategic presence in the pharmaceutical market as well as international markets.
Who invested in Zhejiang Arthur Pharmaceutical Co.
12 investors across 3 rounds
See all investors in Zhejiang Arthur Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zhejiang Arthur Pharmaceutical Co.
Who invested in Zhejiang Arthur Pharmaceutical Co.?
Zhejiang Arthur Pharmaceutical Co. has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zhejiang Arthur Pharmaceutical Co. raised?
Zhejiang Arthur Pharmaceutical Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zhejiang Arthur Pharmaceutical Co. last raise money?
Zhejiang Arthur Pharmaceutical Co.'s most recent round on record is a Series B, in Jun 2024.
What does Zhejiang Arthur Pharmaceutical Co. do?
, Ltd is a drugs' developer that provides generic and innovative drugs.
Where is Zhejiang Arthur Pharmaceutical Co. headquartered?
Zhejiang Arthur Pharmaceutical Co. is headquartered in Jiaxing, China.
Which VCs invest in companies like Zhejiang Arthur Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Zhejiang Arthur Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Zhejiang Arthur Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.